BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26191242)

  • 21. Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis.
    Zhang M; Wang W; Li T; Yu X; Zhu Y; Ding F; Li D; Yang T
    Biomed Pharmacother; 2016 May; 80():73-79. PubMed ID: 27133041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
    Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
    Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of LncRNA SRA1 in hepatocellular carcinoma and its clinical significance.
    Luo P; Jing W; Zhu M; Li ND; Zhou H; Yu MX; Liang CZ; Tu JC
    Cancer Biomark; 2017; 18(3):285-290. PubMed ID: 28085012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
    Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
    Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of Long Non-Coding RNA PlncRNA-1 Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
    Dong L; Ni J; Hu W; Yu C; Li H
    Cell Physiol Biochem; 2016; 38(2):836-46. PubMed ID: 26906068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
    Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
    Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lncRNA MALAT1 promotes HCC metastasis through the peripheral vascular infiltration via miRNA-613: a primary study using contrast ultrasound.
    Zhou D; Wang Y; Hu H; Liu H; Deng J; Li L; Zheng C
    World J Surg Oncol; 2022 Jun; 20(1):203. PubMed ID: 35706002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
    Peng W; Fan H
    Biomed Pharmacother; 2016 Oct; 83():450-455. PubMed ID: 27427851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of long non‑coding HOTAIR correlated with hepatocarcinogenesis and metastasis.
    Zhong DN; Luo YH; Mo WJ; Zhang X; Tan Z; Zhao N; Pang SM; Chen G; Rong MH; Tang W
    Mol Med Rep; 2018 Jan; 17(1):1148-1156. PubMed ID: 29115524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA NEAT1 sponges miR-214 to promoted tumor growth in hepatocellular carcinoma.
    Yeermaike A; Gu P; Liu D; Nadire T
    Mamm Genome; 2022 Sep; 33(3):525-533. PubMed ID: 35357550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of long non-coding RNA
    Liao X; Chen J; Luo D; Luo B; Huang W; Xie W
    Pathol Oncol Res; 2022; 28():1610808. PubMed ID: 36685103
    [No Abstract]   [Full Text] [Related]  

  • 34. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of a novel LncRNA AC104958.2 stabilized by PCBP2 promotes proliferation and microvascular invasion in hepatocellular carcinoma.
    Ma Z; Li S; Wang Y; Zhang J; Zeng X
    Exp Cell Res; 2021 Oct; 407(1):112791. PubMed ID: 34418457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
    Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
    Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA NEAT1 promotes autophagy via regulating miR-204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma.
    Li X; Zhou Y; Yang L; Ma Y; Peng X; Yang S; Li H; Liu J
    J Cell Physiol; 2020 Apr; 235(4):3402-3413. PubMed ID: 31549407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2.
    Jin L; He Y; Tang S; Huang S
    J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway.
    Pan W; Li W; Zhao J; Huang Z; Zhao J; Chen S; Wang C; Xue Y; Huang F; Fang Q; Wang J; Brand D; Zheng SG
    Mol Oncol; 2019 Oct; 13(10):2246-2258. PubMed ID: 31368655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.